ODSH at 0.125 mg/kg/h
PGX-ODSH-2009-PLE
Phase 1 small_molecule terminated
Quick answer
ODSH at 0.125 mg/kg/h for Protein Losing Enteropathy is a Phase 1 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Protein Losing Enteropathy
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated